Loading…
A simple one-step method for isolating highly purified plasmacytoid dendritic cells from human peripheral blood (78.33)
Plasmacytoid dendritic cells (pDC) and myeloid DC (mDC) are the two major human dendritic cell populations. Each subset comprises only a small fraction of peripheral blood mononuclear cells (PBMC) and current protocols for their isolation are time consuming, involve multiple steps and often require...
Saved in:
Published in: | The Journal of immunology (1950) 2009-04, Vol.182 (1_Supplement), p.78-78.33 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Plasmacytoid dendritic cells (pDC) and myeloid DC (mDC) are the two major human dendritic cell populations. Each subset comprises only a small fraction of peripheral blood mononuclear cells (PBMC) and current protocols for their isolation are time consuming, involve multiple steps and often require special equipment. We have developed a rapid and efficient method for the isolation of pDCs from normal blood that yields excellent cell purities and recoveries. Briefly, PBMCs are isolated by Ficoll-Paque PLUS density gradient sedimentation and pDCs are isolated using immuno-magnetic, column-free, negative selection (EasySep®). Our EasySep® technology involves specifically labeling unwanted cells with a cocktail of bi-specific tetrameric antibody complexes and dextran-coated magnetic particles. Using a hand-held magnet, unwanted cells can then be easily removed from the unlabeled pDCs. Flow cytometric assessment of EasySep® isolated pDCs (Lin-, HLA-DR+, BDCA-4+) demonstrate purities of 93.8% ± 3.8% with cell recoveries of 65.6% ± 16.2% (n=9). Using our RoboSep® cell separator, the entire separation procedure can be fully automated with equivalent cell purities and recoveries.
A.I.K is supported by an NSERC Industrial R&D Fellowship |
---|---|
ISSN: | 0022-1767 1550-6606 |
DOI: | 10.4049/jimmunol.182.Supp.78.33 |